REBECCA AMADOR: Open Payments
NPI 1235413840 · TIGARD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 55 payments from 17 companies in 2025. Trend: 2023 $1,133 · 2024 $1,024 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $198 |
| PFIZER INC. | 20 | $143 |
| TerSera Therapeutics LLC | 5 | $103 |
| Merck Sharp & Dohme LLC | 4 | $102 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $33 |
| Tempus AI, Inc | 1 | $29 |
Products named: LYNPARZA, PADCEV, KEYTRUDA, Xermelo, TALVEY, IBRANCE, SCEMBLIX, Enhertu.
Industry payments across OR — which companies pay providers there.
